Literature DB >> 1802234

A survey of potential problems and quality control in peptide synthesis by the fluorenylmethoxycarbonyl procedure.

J D Fontenot1, J M Ball, M A Miller, C M David, R C Montelaro.   

Abstract

The routine production of peptides by manual or automated solid-phase synthesis protocols has gained widespread usage among a variety of biological scientists as new synthetic procedures have been introduced over the past several years. We report here a detailed analysis of Fmoc synthesis procedures to identify problematic reactions and to evaluate analytical procedures for monitoring the quality of peptides during and after synthesis. The results of these studies demonstrate double additions of particular amino acids during single coupling cycles, frequent incomplete deblocking of peptides by standard piperidine reactions, and the failure of the Kaiser ninhydrin test to detect free amino groups of certain amino acids at the N-terminus of synthetic peptides. These results suggest the need for more careful monitoring of Fmoc synthesis reactions than previously recognized or recommended in standard protocols. We demonstrate the utility of plasma desorption mass spectrometry (PDMS) in analyzing peptide products and recommend a minimum sequence of analytical quality control including HPLC and PDMS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1802234

Source DB:  PubMed          Journal:  Pept Res        ISSN: 1040-5704


  11 in total

1.  Thermodynamic assessment of the stability of thrombin receptor antagonistic peptides in hydrophobic environments.

Authors:  Reinhard I Boysen; Agnes J O Jong; Milton T W Hearn
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

2.  Distinct subsets of retroviruses encode dUTPase.

Authors:  J H Elder; D L Lerner; C S Hasselkus-Light; D J Fontenot; E Hunter; P A Luciw; R C Montelaro; T R Phillips
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

3.  Stability and specificity of heterodimer formation for the coiled-coil neck regions of the motor proteins Kif3A and Kif3B: the role of unstructured oppositely charged regions.

Authors:  M S Chana; B P Tripet; C T Mant; R Hodges
Journal:  J Pept Res       Date:  2005-02

4.  De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.

Authors:  Berthony Deslouches; Shruti M Phadke; Vanja Lazarevic; Michael Cascio; Kazi Islam; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins.

Authors:  S B Tencza; J P Douglass; D J Creighton; R C Montelaro; T A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

6.  Development of a fluorescence polarization-based diagnostic assay for equine infectious anemia virus.

Authors:  S B Tencza; K R Islam; V Kalia; M S Nasir; M E Jolley; R C Montelaro
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis.

Authors:  J D Fontenot; E A Hoover; J H Elder; R C Montelaro
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

8.  Testing of viscous anti-HIV microbicides using Lactobacillus.

Authors:  B J Moncla; K Pryke; L C Rohan; H Yang
Journal:  J Microbiol Methods       Date:  2011-12-24       Impact factor: 2.363

9.  Importance of secondary structural specificity determinants in protein folding: insertion of a native beta-sheet sequence into an alpha-helical coiled-coil.

Authors:  Stanley C Kwok; Colin T Mant; Robert S Hodges
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

10.  Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.

Authors:  J M Ball; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.